Tech Company Financing Transactions
Lodo Therapeutics Funding Round
Lodo Therapeutics, based in New York, scored $17 million in investment from AbbVie Biotech Ventures, Alexandria Venture Investments and Arch Venture Partners.
Transaction Overview
Company Name
Announced On
1/13/2016
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
New York, NY 10023
USA
New York, NY 10023
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
Lodo Therapeutics' office and lab headquarters will be located within Accelerator's facilities at the Alexandria Center for Life Science, New York City's first and only premier life science park.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
David Pompliano
Browse more venture capital transactions:
Prev: 1/13/2016: ALung Technologies venture capital transaction
Next: 1/13/2016: Trove Predictive Data Science venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions on this site come from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs